Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-1-29
|
pubmed:abstractText |
A three-dimensional model of the human 5-HT(1a) receptor was constructed by molecular modelling, and the molecular and electronic structures of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin (UH-301) and of (R)- and (S)-8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) were examined by molecular mechanics and quantum mechanics calculations and molecular dynamics simulations. The receptor model has seven transmembrane alpha-helices (TMHs), organized according to a projection map of visual rhodopsin, and includes all loops between helices and the N- and C-terminal parts. Interactions of UH-301 and 8-OH-DPAT with the 5-HT(1a) receptor were examined by molecular dynamics simulations and energy minimization of receptor-ligand complexes. 8-OH-DPAT had lower electrostatic potentials around the hydroxyl group and stronger hydrogen bonding to the receptor model than had UH-301. The simulations indicated that the 5-HT(1a) receptor agonists, (R)- and (S)-8-OH-DPAT and (R)-UH-301, interacted with the receptor at a site closer to Asp82 in TMH2 than did (S)-UH-301, which is a 5-HT1a receptor antagonist. Simulations of receptor-ligand complexes indicated that Asp82, Asp116, Serl99, Thr2OO and Ile385 are essential for binding of both agonist and antagonist to the receptor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/7-hydroxy-2-N,N-dipropylaminotetrali...,
http://linkedlifedata.com/resource/pubmed/chemical/8-Hydroxy-2-(di-n-propylamino)tetral...,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydronaphthalenes,
http://linkedlifedata.com/resource/pubmed/chemical/UH 301
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0269-2139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
149-60
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9005436-8-Hydroxy-2-(di-n-propylamino)tetralin,
pubmed-meshheading:9005436-Chemical Phenomena,
pubmed-meshheading:9005436-Chemistry,
pubmed-meshheading:9005436-Dopamine Agonists,
pubmed-meshheading:9005436-Humans,
pubmed-meshheading:9005436-Hydrogen Bonding,
pubmed-meshheading:9005436-Models, Molecular,
pubmed-meshheading:9005436-Molecular Structure,
pubmed-meshheading:9005436-Protein Binding,
pubmed-meshheading:9005436-Protein Conformation,
pubmed-meshheading:9005436-Receptors, Serotonin,
pubmed-meshheading:9005436-Serotonin Antagonists,
pubmed-meshheading:9005436-Tetrahydronaphthalenes
|
pubmed:year |
1996
|
pubmed:articleTitle |
Molecular modelling of UH-301 and 5-HT(1a) receptor interactions.
|
pubmed:affiliation |
Department of Pharmacology. Institute of Medical Biology, University of Tromsø, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|